Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction

Clinical trial NCT05531955 · UNKNOWN

Trial details

NCT number: NCT05531955
Sponsor: Shanghai Zhongshan Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myocardial Fibrosis

Start date: 2022-08-05
Primary completion: 2024-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.